Boehringer's Stiolto Respimat misses in Phase III for COPD

By Claire Quang | May 11, 2018 | 6:25 PM GMT

In March, Boehringer Ingelheim GmbH (Ingelheim, Germany) reported data from the Phase III DYNAGITO trial in 7,880 patients with chronic obstructive